Literature DB >> 20955906

Contemporary management of the neurogenic bladder for multiple sclerosis patients.

John T Stoffel1.   

Abstract

Urinary symptoms related to multiple sclerosis (MS) present a complex challenge for the treating physician. However, several treatment options are available for the symptomatic patient once the physician understands basic MS disease epidemiology and pathophysiology. Depending of disease status and symptoms, MS urinary symptoms may respond to directed behavioral, pharmacologic, intravesical, neuromodulation, or surgical therapies.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2010        PMID： 20955906     DOI： 10.1016/j.ucl.2010.06.003

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN： 0094-0143            Impact factor:   2.241


  10 in total

1.  Overactive bladder symptoms in patients with multiple sclerosis: Frequency, severity, diagnosis and treatment.

Authors:  Yeşim Akkoç; Murat Ersöz; Nur Yüceyar; Hakan Tunç; Kurtuluş Köklü; Tahir Kurtuluş Yoldaş; Ülkü Dönmez; Cihat Uzunköprü; Ebru Alemdaroğlu; Şule Bilen; Ufuk Emre; Şenay Özdolap; Elif Tuncay; Canan Yücesan; Haydar Gök; Merve Bahar Ercan; Kürşat Uygunol; Belgin Koçer; Murat Zinnuroğlu
Journal:  J Spinal Cord Med       Date:  2016-02-15       Impact factor: 1.985

Review 2.  Botulinum neurotoxin-A treatment of lower urinary tract symptoms in multiple sclerosis.

Authors:  Oussama El Yazami Adli; Jacques Corcos
Journal:  Can Urol Assoc J       Date:  2014-01       Impact factor: 1.862

Review 3.  Evaluation of lower urinary tract symptoms in multiple sclerosis patients: Review of the literature and current guidelines.

Authors:  Shachar Moshe Aharony; Ornella Lam; Jacques Corcos
Journal:  Can Urol Assoc J       Date:  2017 Jan-Feb       Impact factor: 1.862

4.  Associations Between Bladder Dysfunction and Falls in People with Relapsing-Remitting Multiple Sclerosis.

Authors:  Jaime E Zelaya; Charles Murchison; Michelle Cameron
Journal:  Int J MS Care       Date:  2017 Jul-Aug

Review 5.  Autonomic Dysregulation in Multiple Sclerosis.

Authors:  Alexandra Pintér; Domonkos Cseh; Adrienn Sárközi; Ben M Illigens; Timo Siepmann
Journal:  Int J Mol Sci       Date:  2015-07-24       Impact factor: 5.923

6.  The conceptualization and development of a patient-reported neurogenic bladder symptom score.

Authors:  Blayne Welk; Sarah A Morrow; Wendy Madarasz; Patrick Potter; Keith Sequeira
Journal:  Res Rep Urol       Date:  2013-10-10

Review 7.  Detrusor sphincter dyssynergia: a review of physiology, diagnosis, and treatment strategies.

Authors:  John T Stoffel
Journal:  Transl Androl Urol       Date:  2016-02

Review 8.  Secondary and tertiary treatments for multiple sclerosis patients with urinary symptoms.

Authors:  James M Tracey; John T Stoffel
Journal:  Investig Clin Urol       Date:  2016-10-24

9.  Preliminary Analysis of Brain Footprints in Multiple Sclerosis Females With Detrusor Sphincter Dyssynergia: A Concurrent Urodynamic and Functional Magnetic Resonance Imaging Study.

Authors:  Khue Tran; Logan Hubbard; Christof Karmonik; Timothy B Boone; Rose Khavari
Journal:  Int Neurourol J       Date:  2021-12-02       Impact factor: 2.835

10.  A prospective observational cohort study of posterior tibial nerve stimulation in patients with multiple sclerosis: design and methods.

Authors:  Giulia I Lane; Yang Mao-Draayer; Paholo Barboglio-Romo; J Quentin Clemens; Priyanka Gupta; Rod Dunn; Yongmei Qin; Anne P Cameron; John T Stoffel
Journal:  BMC Urol       Date:  2020-05-27       Impact factor: 2.264
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.